CANC — Tema Oncology ETF

Is CANC overbought or oversold? Here is the current MarketMoodz read.

ETF

Oversold As of November 17, 2026

Tema Oncology ETF (CANC) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The ETF name last closed at $40.26. The rating moved from Overbought to Oversold on November 13, 2026.

See all oversold ETF stocks →

AI analysis

Tema Oncology ETF provides concentrated exposure to oncology and stands to benefit from earnings-driven growth flows and interest in thematic/active wrappers. Short-term performance will be driven by binary biotech events, fund flows, and episodic retail-derived volatility; limited direct disclosure and social signal data raise uncertainty around near-term catalysts. Over the coming month the fund may show modest upside if sector momentum persists, but elevated event-driven and concentration risks warrant a cautious stance.

Key factors

  • Pure oncology thematic exposure gives targeted growth potential tied to drug development and biotech upside
  • Earnings-driven market environment and broader growth flows support demand for sector/thematic ETFs
  • Active/alternatives inflows trend supports ETF wrappers and could benefit specialized funds managed by active teams
  • Limited public filing and social sentiment data increases reliance on macro and sector signals rather than issuer fundamentals
  • Potential for episodic volatility from retail derivative flows (0DTE, autocallable products) and concentrated biotech positions
  • Geopolitical and policy headlines can drive tactical reallocations that intermittently benefit or hurt niche thematic ETFs

Risks

  • High idiosyncratic risk from clinical-trial failures, FDA decisions, or binary biotech events within underlying holdings
  • Concentration risk: a small set of biotech/oncology names could materially move fund returns
  • Retail-derivative and autocallable product volatility could create sharp intraday/short-term swings
  • Regulatory or policy shifts (broker rules, product access, or sector regulation) that affect derivative flow or ETF access
  • Geopolitical headlines and risk-off rotations that push flows into safe-haven assets and away from specialty growth ETFs
  • Limited transparency on holdings turnover and manager decisions (if actively managed) increases uncertainty for investors

Latest MarketMoodz coverage

See today's live rating, score and targets

Members see the live hourly rating for CANC — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.